← FDA MEDWATCH
FDA (US) · FDA PRESS RELEASESeptember 29, 2026
FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
FDA Press Release
Published
September 29, 2026
Source
U.S. FDA (MedWatch / press releases)
What this signals · SPEQ interpretation
SPEQ reads this FDA MedWatch item’s stated subject as touching distribution & cold chain. That is a keyword reading of the published subject, not an official classification — the requirements and playbooks below are where a team would look to prevent or close it.
Requirements behind it
2013/C 343/01EU Guidelines on Good Distribution Practice of Medicinal ProductsMHRA GDPUK Good Distribution Practice (Rules & Guidance for Distributors)
Decode the practice
DisciplinesGDP
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →